Literature DB >> 29533902

Hodgkin lymphoma cell lines: to separate the wheat from the chaff.

Hans G Drexler1, Claudia Pommerenke1, Sonja Eberth1, Stefan Nagel1.   

Abstract

Characteristic components of Hodgkin lymphoma (HL) tissue are the mono- or multinucleated Hodgkin-Reed-Sternberg (HRS) cells. Given the challenges of isolating these rare malignant cells and the difficulty in culturing cells from patients, many investigators have tried to establish cell lines in efforts to develop cellular tools for in vitro studies. A limited number of HL cell lines exist and have provided valuable insights into HL pathobiology. A literature survey indicated that 35 cell lines derived from HL patients have been published. To determine whether all these alleged HL cell lines hold up to scrutiny, we examined the available data and also put some of these cell lines to the test of hierarchical clustering, providing additional information regarding assignment to cell line type and tissue derivation. Hierarchical clustering separated the bona fide (classical) HL cell lines completely from cell lines derived from other lymphoma categories and proved conclusively that HL cell lines represent a distinct entity, irrespective of the cellular origin of the HRS cells. We conclude by pointing out the need for an intensified search for new cell culture avenues in order to develop a new generation of informative HL cell lines covering more widely the spectrum of HL stages and subtypes.

Entities:  

Keywords:  Hodgkin; cell lines; lymphoma

Mesh:

Year:  2018        PMID: 29533902     DOI: 10.1515/hsz-2017-0321

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  7 in total

1.  Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells.

Authors:  Sakthi Rajendran; Yating Li; Evelyn Ngoh; Hiu Yi Wong; Man Si Cheng; Cheng-I Wang; Herbert Schwarz
Journal:  Front Oncol       Date:  2019-09-24       Impact factor: 6.244

Review 2.  Deregulated NKL Homeobox Genes in B-Cell Lymphoma.

Authors:  Stefan Nagel; Hans G Drexler
Journal:  Cancers (Basel)       Date:  2019-11-26       Impact factor: 6.639

Review 3.  The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.

Authors:  Hans G Drexler; Hilmar Quentmeier
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

Review 4.  Genomic Landscape of Hodgkin Lymphoma.

Authors:  Magdalena M Brune; Darius Juskevicius; Jasmin Haslbauer; Stefan Dirnhofer; Alexandar Tzankov
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

5.  Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma.

Authors:  Stefan Nagel; Corinna Meyer; Sonja Eberth; Josephine Haake; Claudia Pommerenke
Journal:  Biomedicines       Date:  2022-07-06

6.  Oncolytic Viruses in the Therapy of Lymphoproliferative Diseases.

Authors:  P O Vorobyev; F E Babaeva; A V Panova; J Shakiba; S K Kravchenko; A V Soboleva; A V Lipatova
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

Review 7.  Molecular Pathogenesis of Hodgkin Lymphoma: Past, Present, Future.

Authors:  Marc Bienz; Salima Ramdani; Hans Knecht
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.